文献速递临床生化临床免疫

原发性醛固酮增多症诊断新见解:一项前瞻性多中心研究

New insights in primary aldosteronism diagnosis: a prospective multicenter study.
PubMed 文献 · Clin Chem Lab Med · 2026-06-26

该前瞻性多中心研究纳入676例疑似原发性醛固酮增多症(PA)患者,采用新型夹心免疫分析法检测血浆醛固酮浓度(PAC)和肾素浓度(PRC)。研究发现ARR切点11 ng/L/mU/L灵敏度90%、特异度62%,卡托普利试验后PAC与坐位盐水负荷试验后PAC诊断性能相当,采用化学发光夹心免疫分析法时需调整现有切点。

要点

  • ARR切点11 ng/L/mU/L诊断PA灵敏度90%、特异度62%。
  • 卡托普利试验后PAC与坐位盐水负荷试验后PAC诊断性能无显著差异。
  • 使用新型夹心免疫分析法时需调整PA筛查和确认切点。

核心结论

  • 使用更准确的化学发光夹心免疫分析法检测PAC和PRC时,需调整当前PA筛查和确认的切点值。

研究设计与样本

  • 前瞻性多中心研究,连续纳入中国7个医学中心676例疑似PA患者,所有受试者行卡托普利挑战试验(CCT),第3天行坐位盐水负荷试验(sSIT),用全自动化学发光免疫分析平台(Maglumi X8,SNIBE,中国)检测PAC和PRC,按现行临床指南诊断PA。

主要发现

  • ARR切点11 ng/L/mU/L诊断PA的灵敏度90%(95%CI:85-94%),特异度62%(95%CI:58-67%),AUC为0.843(95%CI:0.81-0.87)。
  • sSIT后PAC与CCT后PAC诊断性能相当(AUC 0.818,95%CI:0.79-0.85 vs. AUC 0.848,95%CI:0.82-0.88;p=0.1388)。
  • sSIT后PAC切点56 ng/L和CCT后PAC切点59 ng/L对应特异度85%(95%CI:81-88%)。
  • 要达到90%特异度,sSIT后PAC切点升至64 ng/L,CCT后PAC切点升至66 ng/L。

关键数值与推荐

  • ARR切点11 ng/L/mU/L:灵敏度90%(95%CI:85-94%),特异度62%(95%CI:58-67%)。
  • sSIT后PAC切点56 ng/L和CCT后PAC切点59 ng/L:特异度85%(95%CI:81-88%)。
  • sSIT后PAC切点64 ng/L和CCT后PAC切点66 ng/L:特异度90%。

临床怎么用

  • 采用化学发光夹心免疫分析法检测PAC和PRC时,应考虑调整PA筛查和确认的切点值。
  • 可根据所需特异度选择sSIT后或CCT后PAC切点,如85%特异度对应56 ng/L和59 ng/L,90%特异度对应64 ng/L和66 ng/L。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The high variability in screening and confirmatory cut-off values for primary aldosteronism (PA) largely reflects the insufficient standardization of current analytical methods. Competitive and sandwich immunoassays show variable correlation with the reference liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique. This prospective multicenter study aimed to establish diagnostic thresholds for PA using a novel sandwich immunoassay. METHODS: A total of 676 patients suspected of PA were consecutively enrolled from 7 medical centers in China. All participants underwent a captopril challenge test (CCT), followed by a seated saline infusion test (sSIT) on the third day. Plasma aldosterone concentration (PAC) and plasma renin concentration (PRC) were measured using a fully automated chemiluminescent immunoassay platform (Maglumi X8, SNIBE, China). PA was diagnosed according to current clinical guidelines. RESULTS: An aldosterone renin ratio (ARR) cut-off of 11 ng/L/mU/L showed 90 % sensitivity (95 % CI: 85-94 %) and 62 % specificity (95 % CI: 58-67 %) with the area under the receiver-operator characteristic curves (AUC) of 0.843 (95 % CI: 0.81-0.87). PAC post-sSIT and PAC post-CCT exhibited comparable diagnostic performance (AUC 0.818, 95 % CI: 0.79-0.85 vs. AUC 0.848, 95 % CI: 0.82-0.88; p=0.1388). Using cut-off of 56 ng/L and 59 ng/L for post-SIT and post-CCT yielded a specificity of 85 % (95 % CI: 81-88 %). Notably, to achieve a higher specificity of 90 %, the corresponding PAC cut-off values increased to 64 ng/L post-SIT and 66 ng/L post-CCT. CONCLUSIONS: Adjustment of current cut-off values for the screening and confirmation of PA is necessary when a more accurate chemiluminescent sandwich immunoassay is used for measuring PAC and PRC.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Wang K, Ma W, Cong H, et al. New insights in primary aldosteronism diagnosis: a prospective multicenter study. Clin Chem Lab Med. 2026. PMID: 42343549. doi:10.1515/cclm-2026-0579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。